Comparative study of endometrial thickness with transabdominal ultrasonography and pelvis in perimenopausal women presenting with abnormal uterine bleeding and correlation with its histopathological findings

Authors

  • Rita D. Department of Obstetrics and Gynecology, NMCH and RC, Raichur, Karnataka, India
  • Pallavi Sourya K. A. Department of Obstetrics and Gynecology, NMCH and RC, Raichur, Karnataka, India
  • Lathasri A. Department of Obstetrics and Gynecology, NMCH and RC, Raichur, Karnataka, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20231926

Keywords:

Heavy menstural bleeding, Endometrial thickness, Perimenopausal, Transabdominal sonography, Dilatation and curettage

Abstract

Background: Heavy menstrual bleeding is the most common presenting menstrual complaint in women of perimenopausal age group. Diagnostics tests to investigate the causes of abnormal bleeding are transabdominal ultrasonography (TAS), TVS, endometrial biopsy and uterine curettage which is invasive procedure performed under anesthesia. The objectives of this study were to correlate the transabdominal ultrasonography results with the histopathological findings to discriminate normal from pathological endometrium.

Methods: Comparative study including 100 perimenopausal women with abnormal uterine bleeding. Endometrial thickness was measured by TAS and then D and C was performed for all the patients.

Results: Out of 100 women, (86) had normal and (14) had an abnormal endometrium. 43 were of 41-45 years and 65 patients presented with complaint of heavy menstrual bleeding. Fibroid uterus (24%) was the commonest uterine pathology detected on TAS. 53 of patients had endometrial thickness in the range 10-11.9 mm. Most common finding on HPE was secretory endometrium (44). Endometrial carcinoma was found in 1. Endometrial thickness <12mm was associated with least abnormal endometrial pathology.

Conclusions: Irrespective of endometrial thickness all perimenopausal women with HMB should be subjected to TAS followed by D and C which helps in early detection and missing out of endometrial carcinoma.

References

Walker MH, Coffey W, Borger J. Menorrhagia. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023:4.

Munro MG, Critchley HO, Broder MS, Fraser IS, FIGO Working Group on Menstrual Disorders. FIGO classification system (PALM‑COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet. 2011;113:3‑13.

Hoffman BL, Schorge JO, Bradshaw KD, Halvorson LM, Schaffer JI, Corton MM. Williams textbook of gynaecology. 4th ed. New York, NY: McGraw Hill/Medical; 2020: 705.

Kotdawala P, Kotdawala S, Nagar N. Evaluation of endometrium in peri-menopausal abnormal uterine bleeding. J Mid-Life Heal. 2013;4(1):16.

Sajitha K, Padma SK, Shetty KJ, Kishan Prasad HL, Permi HS, Hegde P. Study of histopathological patterns of endometrium in abnormal uterine bleeding. CHRISMED J Health Res. 2014;1(2):76.

Patil SG, Bhute SB, Inamdar SA, Acharya S, Shrivastava DS. Role of diagnostic hysteroscopy in abnormal uterine bleeding and its histopathological correlation. J Gynecol Endosco Surg. 2009;1(2):98.

Jetley S, Rana S, Jairajpuri ZS. Morphological spectrum of endometrial pathology in middle aged women with atypical uterine bleeding - a study of 219 cases. J Midlife Heal. 2013;4(4):216-20.

Cornitescu F, Tanase F, Simionescu C, Iliescu D. Clinical, histopathological and therapeutic consideration in non-neoplastic abnormal uterine bleeding in menopause transition. Rom J Morphol Embryol. 2011;52(3):759-65.

Sur D, Chakravorty R. Correlation of endometrial thickness and histopathology in women with abnormal uterine bleeding. Repro Syst Sexual Dis. 2016;5(4):1-3.

Begum NA, Chandra LH, Pukale RS. Evaluation of endometrial thickness with transvaginal ultrasonography in perimenopausal women presenting with abnormal uterine bleeding and correlation with its histopathological findings. Int J Reprod Contracep Obstet Gynecol. 2019;8(11):4496-503.

Getpook C, Wattanakumtornkul S. Endometrial thickness screening in premenopausal women with abnormal uterine bleeding. J Obstet Gynaecol Res. 2006;32(6):588-92.

Kurman RJ, Kaminski PF, Norris HJ. The behavior of endometrial hyperplasia: a long-term study of “untreated” hyperplasia in 170 patients. Cancer. 1985;56(2):403-12.

Palmer JE, Perunovic B, Tidy JA. Endometrial hyperplasia. The Obstet Gynaecol. 2008;10(4):211-6.

Cheung AP. Ultrasound and menstrual history in predicting endometrial hyperplasia in polycystic ovary syndrome. Obstet Gynecol. 2001;98(2):325-31.

Giannella L, Cerami LB, Setti T, Bergamini E, Boselli F. Prediction of endometrial hyperplasia and cancer among premenopausal women with abnormal uterine bleeding. BioMed Res Inter. 2019;2019:8598152.

Royal College of Obstetrician and Gynecologist. Management of Endometrial Hyperplasia (Green-top Guideline No. 67), 2016. Available at: https://www.rcog.org.uk/globalassets/documents/guidelines/green-top-guidelines/gtg_67_endometrial _hyperplasia.pdf. Accessed 01 February 2020.

Downloads

Published

2023-06-28

Issue

Section

Original Research Articles